UB Paderborn / Katalog / Suche / in CDI

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer

Breast cancer research : BCR, 2022-11, Vol.24 (1), p.74-74, Article 74

2022

Link zum Volltext

Verfügbarkeit prüfen

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer

Cancers, 2021-11, Vol.13 (21), p.5501

2021

Link zum Volltext

Verfügbarkeit prüfen

Pathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score and dietary intervention response

Diagnostic pathology, 2023-11, Vol.18 (1), p.1-122, Article 122

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer

Cancers, 2021-03, Vol.13 (5), p.1024

2021

Link zum Volltext

Verfügbarkeit prüfen

Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 ( HER2 ) Status in Invasive Breast Carcinoma

The Journal of molecular diagnostics : JMD, 2013-03, Vol.15 (2), p.210-219

2013

Link zum Volltext

Verfügbarkeit prüfen

Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung

Archives of pathology & laboratory medicine (1976), 2012-11, Vol.136 (11), p.1339-1346

2012

Link zum Volltext

Verfügbarkeit prüfen

Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

American journal of clinical pathology, 2013-11, Vol.140 (5), p.736-746

2013

Link zum Volltext

Verfügbarkeit prüfen

Extensive chromosomal instability in Rad51d-deficient mouse cells

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (6), p.2089-2096

2005

Link zum Volltext

Verfügbarkeit prüfen

interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysis

Proteomics (Weinheim), 2009-08, Vol.9 (16), p.4071-4086

2009

Link zum Volltext

Verfügbarkeit prüfen

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.80-90

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeted Quantitative Mass Spectrometry Analysis of Protein Biomarkers From Previously Stained Single Formalin-Fixed Paraffin-Embedded Tissue Sections

Laboratory investigation, 2023-04, Vol.103 (4), p.100052-100052, Article 100052

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer

Scientific reports, 2020-06, Vol.10 (1), p.9805-9805, Article 9805

2020

Link zum Volltext

Verfügbarkeit prüfen

Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry

Laboratory investigation, 2020-06, Vol.100 (6), p.874-886

2020

Link zum Volltext

Verfügbarkeit prüfen

Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomas

The American journal of surgical pathology, 2012-10, Vol.36 (10), p.1527-1537

2012

Link zum Volltext

Verfügbarkeit prüfen

A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone

Applied immunohistochemistry & molecular morphology, 2022-04, Vol.30 (4), p.237

2022

Link zum Volltext

Verfügbarkeit prüfen

MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis

Journal of surgical oncology, 2018-06, Vol.117 (8), p.1679-1686

2018

Link zum Volltext

Verfügbarkeit prüfen

MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma

Modern pathology, 2020-06, Vol.33 (6), p.1015-1032

2020

Link zum Volltext

Verfügbarkeit prüfen

Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory

Archives of pathology & laboratory medicine (1976), 2015-10, Vol.139 (10), p.1201-1201

2015

Link zum Volltext

Verfügbarkeit prüfen

A novel immunohistochemical scoring system reveals associations of C-terminal MET, ectodomain shedding, and loss of E-cadherin with poor prognosis in oral squamous cell carcinoma

Human pathology, 2020-10, Vol.104, p.42-53

2020

Link zum Volltext

Verfügbarkeit prüfen

Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma

Journal of Clinical Pathology, 2010-03, Vol.63 (3), p.210-219

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classification

Archives of pathology & laboratory medicine (1976), 2011-05, Vol.135 (5), p.544-557

2011

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States

Clinical lymphoma, myeloma and leukemia, 2017-04, Vol.17 (4), p.193-200

2017

Link zum Volltext

Verfügbarkeit prüfen

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma

Oncotarget, 2013-10, Vol.4 (10), p.1662-1672

2013

Link zum Volltext

Verfügbarkeit prüfen

Congenital mesoblastic nephroma

The Journal of urology, 2010-03, Vol.183 (3), p.1188

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer

Pathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score and dietary intervention response

Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer

Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 ( HER2 ) Status in Invasive Breast Carcinoma

Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung

Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

Extensive chromosomal instability in Rad51d-deficient mouse cells

interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysis

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients

Targeted Quantitative Mass Spectrometry Analysis of Protein Biomarkers From Previously Stained Single Formalin-Fixed Paraffin-Embedded Tissue Sections

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer

Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry

Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomas

A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone

MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis

MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma

Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory

A novel immunohistochemical scoring system reveals associations of C-terminal MET, ectodomain shedding, and loss of E-cadherin with poor prognosis in oral squamous cell carcinoma

Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma

Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classification

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma

Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)

Congenital mesoblastic nephroma

Suchergebnisse filtern